Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer

Clinical trial NCT06752811 · RECRUITING

Trial details

NCT number: NCT06752811
Sponsor: Shanghai Yizhong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer Metastatic

Start date: 2025-02-05
Primary completion: 2027-07-01
Enrollment: 416

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.